Search results
How shots instead of pills could change California’s homeless crisis
KPBS San Diego· 2 days agoAs Dr. Rishi Patel’s street medicine van bounces over dirt roads and empty fields in rural Kern...
How To Mentor Our Next Generation Of Leaders
Forbes· 4 days agoThe above paragraph is from the press material for The Financial Times Guide to Mentoring: A Complete Guide to Effective Mentoring by Ruth Gotian and...
Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting
Journal of the American Medical Association· 4 days agoThis cohort study examines whether a watchful waiting treatment strategy is associated with adverse outcomes in men with nonmetastatic prostate cancer and a life expectancy of less than 10 years in Sweden.
Booking Holdings target raised to $4,342 amid travel demand By Investing.com
Investing.com· 4 days agoOn Tuesday, Argus increased the price target for Booking Holdings (NASDAQ:BKNG), a leader in the...
How shots instead of pills could change California’s homeless crisis
Associated Press· 3 days agoAs Dr. Rishi Patel’s street medicine van bounces over dirt roads and empty fields in rural Kern...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 3 days agoAxsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, today announced ...
Ideal Power adds European wafer fabrication site By Investing.com
Investing.com· 3 days agoIdeal Power Inc. (NASDAQ:IPWR), a company specializing in the development of the B-TRAN™...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoLEXINGTON, Mass. and AMSTERDAM, June 03, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical ...
Aptevo Participating in the BIO International Convention
Digital Journal· 5 days ago...the uncertainties inherent in the results of preliminary data and preclinical studies being predictive of the results of later-stage clinical trials, initiation, enrollment and maintenance of patients, and the completion of clinical trials, the availability and timing of data from ongoing...
JD Supra: 2024 Title IX Regulation Update, Part III: Section 106.44
JD Supra· 6 days agoThis is part three of a series examining the most topical changes contained in the new Title IX regulations applicable to higher education, which were released by the U.S. Department of Education ...
